The costs of caring for California community residents with Alzheimer's disease will increase 83 percent by 2020 and an additional 59 percent by 2040, according to UCSF researchers from the Institute for Health and Aging.
April 27, 2001
April 25, 2001
University of California, San Francisco researchers are reporting direct evidence that sleep in early life may play a crucial role in brain development.
April 18, 2001
A new study led by a University of California, San Francisco researcher shows that although raloxifene does not affect the cognitive performance of most women, it may help prevent decline among women older than 70 and women whose cognitive performance is declining regardless of age.
April 11, 2001
In fighting the body's immune system, HIV owes part of its success to its ability to destroy those cells normally recruited to mount the body's counter-attack against the HIV-infected cells...
April 04, 2001
Anecdotes abound about the tumultuous state of physician affairs in California. However, there is no objective evidence that large numbers of doctors are leaving California, according to a report released by the UCSF Center for Health Professions.
April 04, 2001
Physicians are assuming a stronger stance in their negotiations with managed care organizations, and employers and federal and state governments are becoming more sophisticated about promoting and rewarding high quality care, according to UCSF researchers...
April 02, 2001
With only 32 of its 302 nerves dedicated to detecting the odors that drift through its world, the lowly roundworm seems hard pressed to smell food, let alone discriminate friend from foe...
March 28, 2001
Nearly a decade ago, researchers determined that the brain contains a molecule that mimics the active ingredient in marijuana, but its location and role in the brain were unclear...
December 05, 2000
Researchers led by investigators at the University of California, San Francisco have discovered that the protein alpha1-antichymotrypsin can double the accumulation of Alzheimer's disease-associated amyloid plaque in the brains of mice, suggesting a possible new target for therapy in humans.
December 04, 2000
UCSF researchers report that a new approach for delivering the potent growth factor VEGF into mice with coronary heart disease prompted the growth of blood vessels in damaged heart tissue, without causing side effects, offering hope for a treatment strategy for coronary heart disease that until now has met with setbacks. The finding is reported in the current issue of Proceedings of the National Academy of Science.